In this assay, healthy volunteers consume acetaminophen dissolved in yogurt after administration of either a single dose or multiple doses (steady-state) of a drug that putatively alters gastric emptying
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
However, subcutaneous injections are considered a much safer and more convenient form of peptide application in experimental settings
21, no.1 [online] Available at: (accessed 4th April 2022) Ernst, A.M., Gimbel, B.A., de Water, E., Eckerle, J.K., Radke, J.P., Georgieff, M.K
Yaginuma, S
Let's be honest, this is crucial for experimental design